These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9350955)

  • 1. A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia.
    Peuskens J; Link CG
    Acta Psychiatr Scand; 1997 Oct; 96(4):265-73. PubMed ID: 9350955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicentre, double-blind, randomized comparison of quetiapine (ICI 204,636, 'Seroquel') and haloperidol in schizophrenia.
    Copolov DL; Link CG; Kowalcyk B
    Psychol Med; 2000 Jan; 30(1):95-105. PubMed ID: 10722180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group.
    Small JG; Hirsch SR; Arvanitis LA; Miller BG; Link CG
    Arch Gen Psychiatry; 1997 Jun; 54(6):549-57. PubMed ID: 9193196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of bd and tid dose regimens of quetiapine (Seroquel) in the treatment of schizophrenia.
    King DJ; Link CG; Kowalcyk B
    Psychopharmacology (Berl); 1998 May; 137(2):139-46. PubMed ID: 9630000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.
    Tada M; Shirakawa K; Matsuoka N; Mutoh S
    Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group.
    Arvanitis LA; Miller BG
    Biol Psychiatry; 1997 Aug; 42(4):233-46. PubMed ID: 9270900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the effects of quetiapine ('seroquel') and haloperidol in schizophrenic patients with a history of and a demonstrated, partial response to conventional antipsychotic treatment. PRIZE Study Group.
    Emsley RA; Raniwalla J; Bailey PJ; Jones AM
    Int Clin Psychopharmacol; 2000 May; 15(3):121-31. PubMed ID: 10870870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An analysis of safety and tolerability data from controlled, comparative studies of quetiapine in patients with schizophrenia, focusing on extrapyramidal symptoms.
    Timdahl K; Carlsson A; Stening G
    Hum Psychopharmacol; 2007 Jul; 22(5):315-25. PubMed ID: 17542047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized, double-blind, placebo-controlled study of paliperidone extended-release and quetiapine in inpatients with recently exacerbated schizophrenia.
    Canuso CM; Dirks B; Carothers J; Kosik-Gonzalez C; Bossie CA; Zhu Y; Damaraju CV; Kalali AH; Mahmoud R
    Am J Psychiatry; 2009 Jun; 166(6):691-701. PubMed ID: 19411369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quetiapine: efficacy and tolerability in schizophrenia.
    Kasper S; Tauscher J; Heiden A
    Eur Neuropsychopharmacol; 2001 Oct; 11 Suppl 4():S405-13. PubMed ID: 11587888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind comparison of risperidone, quetiapine and placebo in patients with schizophrenia experiencing an acute exacerbation requiring hospitalization.
    Potkin SG; Gharabawi GM; Greenspan AJ; Mahmoud R; Kosik-Gonzalez C; Rupnow MF; Bossie CA; Davidson M; Burtea V; Zhu Y; Trivedi JK
    Schizophr Res; 2006 Jul; 85(1-3):254-65. PubMed ID: 16797162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 6-week, multicenter, double-blind, double-dummy, chlorpromazine-controlled non-inferiorityrandomized phase iiitrial to evaluate the efficacy and safety of quetiapine fumarate (SEROQUEL) extended-release (XR) in the treatment of patients with schizophrenia and acute episodes.
    Li H; Shen Y; Wang G; Shi J; Ma C; Xie S; Zhang H; Wang X; Li K; Xu X; Gu N
    Psychiatry Res; 2018 Jan; 259():117-124. PubMed ID: 29040947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintenance of long-term efficacy and safety of quetiapine in the open-label treatment of schizophrenia.
    Kasper S; Brecher M; Fitton L; Jones AM
    Int Clin Psychopharmacol; 2004 Sep; 19(5):281-9. PubMed ID: 15289701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of quetiapine in adolescents with schizophrenia investigated in a 6-week, double-blind, placebo-controlled trial.
    Findling RL; McKenna K; Earley WR; Stankowski J; Pathak S
    J Child Adolesc Psychopharmacol; 2012 Oct; 22(5):327-42. PubMed ID: 23083020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ICI 204,636, an atypical antipsychotic: efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia. U.S. SEROQUEL Study Group.
    Borison RL; Arvanitis LA; Miller BG
    J Clin Psychopharmacol; 1996 Apr; 16(2):158-69. PubMed ID: 8690831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quetiapine has equivalent efficacy and superior tolerability to risperidone in the treatment of schizophrenia with predominantly negative symptoms.
    Riedel M; Müller N; Strassnig M; Spellmann I; Engel RR; Musil R; Dehning S; Douhet A; Schwarz MJ; Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 2005 Dec; 255(6):432-7. PubMed ID: 16267634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extrapyramidal symptoms associated with quetiapine.
    Shim SS
    Aust N Z J Psychiatry; 2003 Dec; 37(6):773. PubMed ID: 14636395
    [No Abstract]   [Full Text] [Related]  

  • 18. Quetiapine. A review of its use in the management of schizophrenia.
    Cheer SM; Wagstaff AJ
    CNS Drugs; 2004; 18(3):173-99. PubMed ID: 14871161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quetiapine versus other atypical antipsychotics for schizophrenia.
    Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S
    Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol.
    Dossenbach M; Erol A; el Mahfoud Kessaci M; Shaheen MO; Sunbol MM; Boland J; Hodge A; O'Halloran RA; Bitter I;
    J Clin Psychiatry; 2004 Mar; 65(3):312-21. PubMed ID: 15096069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.